TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
181 hedge funds and large institutions have $1.38B invested in Trillium Therapeutics Inc. in 2021 Q3 according to their latest regulatory filings, with 83 funds opening new positions, 46 increasing their positions, 35 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
32% more funds holding
Funds holding: 137 → 181 (+44)
31% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 35
Holders
181
Holding in Top 10
5
Calls
$85.4M
Puts
$39.1M
Top Buyers
| 1 | +$57.4M | |
| 2 | +$55.1M | |
| 3 | +$41.6M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$40.4M |
| 5 |
VI
Versor Investments
New York
|
+$33.8M |
Top Sellers
| 1 | -$75.2M | |
| 2 | -$59.1M | |
| 3 | -$51.3M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$51.3M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$39.8M |